Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2021-11-23 Director's Dealing
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
DGAP-DD: MorphoSys AG english
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains the header 'DGAP-DD: MorphoSys AG english' followed by 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. Section 4 details the 'Nature of the transaction' as 'Acquisition' by a 'Member of the managing body'. This content directly corresponds to the definition of Director's Dealing reports.
2021-11-23 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in voting rights percentages held by a major shareholder (BlackRock, Inc.) in MorphoSys AG, referencing specific German securities laws (Article 40, Section 1 of the WpHG). This content directly corresponds to the definition of a notification of changes in significant share ownership levels, which aligns best with the 'Major Shareholding Notification' category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the core content is the change in holding percentage, not the results of a general meeting vote (DVA).
2021-11-12 English
Q3 statement / Q3 financial report 2021
Interim / Quarterly Report Classification · 1% confidence The document is a 'Third Quarter Interim Statement' for MorphoSys Group, covering the period January to September 2021. It contains detailed financial results, including consolidated statements of profit or loss, balance sheets, and cash flows, as well as management's discussion of business performance and product pipelines. Since it provides comprehensive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. 9M 2021
2021-11-11 German
MorphoSys AG Reports First Nine Months and Third Quarter 2021 Results
Earnings Release Classification · 1% confidence The document is titled "MorphoSys AG Reports First Nine Months and Third Quarter 2021 Results" and contains detailed financial tables comparing Q3 2021 results against Q3 2020, and 9M 2021 results against 9M 2020. It explicitly mentions financial figures, operating loss, net profit/loss, and provides updated financial guidance for 2021. This content structure is characteristic of a comprehensive financial report covering a period shorter than a full year, specifically an Interim/Quarterly Report. Although it is presented as a news release (DGAP-News), the substance is the detailed financial results for the interim period, making 'Interim / Quarterly Report' (IR) the most appropriate classification over a simple 'Earnings Release' (ER) which usually contains only highlights. 9M 2021
2021-11-10 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in voting rights percentages and holdings due to the acquisition/disposal of shares and instruments by a major shareholder (The Goldman Sachs Group, Inc.). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing thresholds. The German WpHG (Securities Trading Act) references confirm this regulatory context. Therefore, the appropriate code is MRQ.
2021-11-10 English
MorphoSys Announces Departure of Roland Wandeler
Board/Management Information Classification · 1% confidence The document is a 'Media Release' dated November 9, 2021, announcing that Roland Wandeler, the Chief Operating Officer (COO), has decided to step down from his position effective December 31, 2021. This content directly relates to changes in senior management personnel. Based on the provided definitions, this aligns perfectly with the 'Board/Management Information' category.
2021-11-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.